The CD52 antigen and development of the CAMPATH antibodies

被引:141
作者
Hale, G [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
关键词
D O I
10.1080/146532401753174098
中图分类号
Q813 [细胞工程];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:137 / 143
页数:7
相关论文
共 52 条
[1]   Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H [J].
Brett, S ;
Baxter, G ;
Cooper, H ;
Johnston, JM ;
Tite, J ;
Rapson, N .
IMMUNOLOGY, 1996, 88 (01) :13-19
[2]   The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AML [J].
Bunjes, D .
CYTOTHERAPY, 2001, 3 (03) :175-188
[3]   Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients [J].
Calne, R ;
Moffatt, SD ;
Friend, PJ ;
Jamieson, NV ;
Bradley, JA ;
Hale, G ;
Firth, J ;
Bradley, J ;
Smith, KGC ;
Waldmann, M .
TRANSPLANTATION, 1999, 68 (10) :1613-1616
[4]   Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M;: effect on CD34+ cells and progenitor cell recoveries [J].
Clarke, E ;
Potter, MN ;
Hale, G ;
Waldmann, H ;
Lankester, A ;
Cornish, JM ;
Steward, CG ;
Marks, DI ;
Oakhill, A ;
Pamphilon, DH .
BONE MARROW TRANSPLANTATION, 1998, 22 (02) :117-124
[5]   MONOCLONAL-ANTIBODIES FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE AND MARROW GRAFT-REJECTION - THE DEPLETION OF T-CELL SUBSETS INVITRO AND INVIVO [J].
COBBOLD, S ;
MARTIN, G ;
WALDMANN, H .
TRANSPLANTATION, 1986, 42 (03) :239-247
[6]  
Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO
[7]  
2-#
[8]   Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis [J].
Coles, AJ ;
Wing, N ;
Smith, S ;
Coraddu, F ;
Greer, S ;
Taylor, C ;
Weetman, A ;
Hale, G ;
Chatterjee, VK ;
Waldmann, H ;
Compston, A .
LANCET, 1999, 354 (9191) :1691-1695
[9]   Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity [J].
Cull, GM ;
Haynes, AP ;
Byrne, JL ;
Carter, GI ;
Miflin, G ;
Rebello, P ;
Hale, G ;
Waldmann, H ;
Russell, NH .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) :754-760
[10]  
Curtis RE, 1999, BLOOD, V94, P2208